Lundbeck, Otsuka's PTSD bid for Rexulti dealt a setback at FDA advisory committee

21st July 2025 Uncategorised 0

The overwhelmingly negative vote came as a bit of a surprise given that several experts hinted that the combo may potentially be effective.

More: Lundbeck, Otsuka's PTSD bid for Rexulti dealt a setback at FDA advisory committee
Source: fierce